To examine potential glycosylation on SERPINA1, we treated plasma proteins obtained from PC patients and a commercially available recombinant human SERPINA1 protein (derived from a mouse myeloma cell line NS0) with PNGase F to eliminate glycan. This evidence concerns the gene NGLY1 and pachyonychia congenita.